HEMOGLOBINOPATHY MARKET ANALYSIS

Regional Analysis

Global Hemoglobinopathy Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global hemoglobinopathy market over the forecast period. North America holds 45.1% of the market share due to the increasing prevalence of Beta Thalassemia in the region. For instance, in December 2020, according to a report published on National Center for Biotechnology Information (NCBI), stated that in the U.S., the prevalence of beta thalassemia has increased approximately 7.5% over the last 50 years.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa